Supernus Pharmaceuticals is acquiring Indivior in an all-stock deal, assembling a portfolio of 11 FDA-approved CNS treatments. The merger targets $125 million in annual cost synergies and expands the company's footprint in neurology, addiction, and psychiatry. Meanwhile, Q2 revenue jumped 32% to $219 million, but a surprise net loss of $58.1 million casts a shadow over short-term integration risks.
Source: The Motley Fool · Eric Volkman (us)
A potential $400 billion merger between AstraZeneca and Bristol Myers Squibb could reshape oncology competition, with implications for drug costs, patient access, and payer negotiations. The combined portfolio would dominate key cancer markets.
FTC approval paves the way for Aurobindo Pharma to acquire Lannett Company, adding a 4 billion dose manufacturing facility and complex non-opioid generics portfolio to its network, directly supporting US efforts to boost domestic drug production and address the opioid crisis.
Samsung Biologics' tender offer for PolyPeptide brings peptide API manufacturing in-house, reinforcing supply chain resilience for hormone therapies, antibiotics, and emerging biotherapeutics. The deal expands capacity across the U.S., Europe, and India, potentially reducing the risk of shortages that have plagued certain peptide drugs.
Unihealth Hospitals Limited announces a share swap to increase its ownership in Victoria Hospital from 50% to 99.81%, consolidating a key East African asset. The transaction will be entirely equity-based, preserving cash for further expansion and delivering full financial benefits to Unihealth shareholders.
Source: sierraleonetimes.com · indiagazette.com
H.B. Fuller's $870 million acquisition of Advanced Medical Solutions signals a major vote of confidence in advanced wound care and surgical sealants. For healthcare providers, this deal promises innovative products for chronic wounds and surgical closures, potentially improving patient outcomes and reducing costs.
Infosys has announced the acquisition of Optimum Healthcare IT to accelerate AI-driven digital transformation for healthcare providers. The move strengthens Infosys' position in the high-growth healthcare IT sector by integrating specialized consulting and implementation expertise.
Source: PR Newswire · PR Newswire
Merck has reached a definitive agreement to acquire Terns Pharmaceuticals for $6.7 billion, securing a promising Phase 2 leukemia treatment. The cash deal is a strategic move to diversify Merck's oncology portfolio as it prepares for the 2028 patent expiration of its blockbuster drug Keytruda.
Source: STAT News · Bloomberg
Merck has entered into a definitive agreement to acquire Terns Pharmaceuticals for $6.7 billion, a strategic move designed to diversify its oncology portfolio. The acquisition comes as Merck prepares for the impending patent expiration of its top-selling cancer immunotherapy, Keytruda, later this decade.
Source: abcnews.com · clickorlando.com
Global food giant Danone has reached a definitive agreement to acquire Hertfordshire-based Huel in a deal valued at approximately $1.2 billion. The acquisition marks a significant acceleration of Danone's strategy to dominate the high-growth functional nutrition and meal-replacement markets.
Source: hertsad.co.uk · thecomet.net
Wellgistics Health Inc. has signed a $105 million Letter of Intent to evaluate the acquisition of Neuritek Therapeutics, a biotech firm specializing in neurological and psychiatric treatments. The deal marks a significant strategic expansion for Wellgistics into the high-growth central nervous system (CNS) therapeutic sector.
Source: jamaicantimes.com · californiatelegraph.com
Novartis AG has entered into a definitive agreement to acquire an experimental breast cancer drug candidate, SNV4818, from Delaware-based Synnovation Therapeutics for up to $3 billion. This strategic acquisition aims to strengthen Novartis's leadership in the oncology market as it continues its pivot toward high-value innovative medicines.
Source: Seeking Alpha · Bloomberg
Universal Health Services (UHS) has entered into a definitive agreement to acquire digital mental health provider Talkspace for $835 million. The deal integrates a massive inpatient hospital network with a leading telehealth platform to create a comprehensive hybrid care model.
Source: pottsmerc.com · thereporteronline.com
Aster DM Healthcare has cleared a critical regulatory hurdle as shareholders and creditors overwhelmingly approved its merger with Quality Care India Limited (QCIL). This consolidation, backed by Blackstone, is set to create one of India's largest private healthcare networks with a significantly expanded bed capacity and geographic footprint.
Source: thehindubusinessline.com · nepalnational.com
Lifeward Ltd shareholders have officially approved a strategic partnership with Oramed Pharmaceuticals, signaling a major pivot toward becoming a diversified biomedical company. The deal integrates Lifeward's robotic rehabilitation technology with Oramed's pharmaceutical expertise to create a multi-disciplinary healthcare entity.
Source: finanznachrichten.de · manilatimes.net
The hospital foundations serving Petrolia and Sarnia have announced a formal amalgamation to consolidate fundraising efforts for the Bluewater Health network. This strategic merger is designed to reduce administrative overhead and create a unified philanthropic voice for healthcare in Lambton County.
Source: stthomastimesjournal.com · norfolkandtillsonburgnews.com
TelkomMetra has divested its stake in AdMedika Group to Fullerton Health, a move that streamlines Telkom Indonesia's portfolio while positioning AdMedika for regional expansion. The acquisition consolidates Fullerton's position as a dominant integrated healthcare provider in the Asia-Pacific region.
Source: laosnews.net · bangladeshsun.com
Universal Health Services (UHS) has reached a definitive agreement to acquire virtual mental health provider Talkspace for $835 million. The deal merges one of the nation's largest inpatient behavioral health networks with a leading digital therapy platform, signaling a major shift toward hybrid care models.
Source: STAT News · Endpoints News
Scantox has acquired the DuplexSeq™ nonclinical genomics safety business from TwinStrand Biosciences, integrating ultra-sensitive DNA sequencing into its pre-clinical service portfolio. The move positions Scantox as a leader in next-generation genetic toxicology, offering 10,000x higher sensitivity than standard sequencing methods.
Source: prnewswire.com · prnewswire.com
US telehealth leader Hims & Hers has finalized a $1.6 billion acquisition of Australian digital health startup Eucalyptus, marking a major expansion into the Asia-Pacific market. The deal, driven by the explosive growth of GLP-1 weight-loss treatments, creates over 100 employee millionaires and solidifies Hims & Hers' position as a global powerhouse in direct-to-consumer healthcare.
About Healthcare Acquisitions coverage
According to our own tracking database, this category has accumulated 20 acquisitions stories since coverage began. This page aggregates the latest acquisitions stories within our healthcare coverage area. Every story is cross-referenced across multiple primary sources, scored for sentiment and operational impact, and timestamped so fresh developments surface first. We track m&a activity and surface the angles a domain expert would actually read.
Story selection follows our editorial methodology — impact scoring weights regulatory, financial, and operational developments distinctly. Sentiment is classified across five tiers via supervised classification trained on labeled industry corpora. See our glossary for term definitions and our trends index for longitudinal patterns across the healthcare beat.
Stories only surface on this page once the classifier scores them at a minimum 35 percent
relevance to the category. According to that methodology, reviewed July 2026, this follows
multi-source corroboration standards recommended by journalism research bodies such as the
Reuters Institute for the Study of Journalism.
See something wrong on this page — a wrong stat, a broken source link, a miscategorized
story? Report a data issue.